Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

3-Deazaneplanocin A

😃Good
Catalog No. T6292Cas No. 102052-95-9
Alias DZNep, 3-Deazaneplanocin

3-Deazaneplanocin A (DZNep) is a dual inhibitor of histone methyltransferase (EZH2) and S-adenosylhomocysteine hydrolase (AHCY) with antipoxidative activity that inhibits hepatic, renal, peritoneal, and airway fibrosis by inducing proteasomal degradation of its targets and reducing toxicity in animal models.

3-Deazaneplanocin A

3-Deazaneplanocin A

😃Good
Purity: 99.68%
Catalog No. T6292Alias DZNep, 3-DeazaneplanocinCas No. 102052-95-9
3-Deazaneplanocin A (DZNep) is a dual inhibitor of histone methyltransferase (EZH2) and S-adenosylhomocysteine hydrolase (AHCY) with antipoxidative activity that inhibits hepatic, renal, peritoneal, and airway fibrosis by inducing proteasomal degradation of its targets and reducing toxicity in animal models.
Pack SizePriceAvailabilityQuantity
1 mg$159In Stock
5 mg$4277-10 days
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Purity:99.68%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
3-Deazaneplanocin A (DZNep) is a dual inhibitor of histone methyltransferase (EZH2) and S-adenosylhomocysteine hydrolase (AHCY) with antipoxidative activity that inhibits hepatic, renal, peritoneal, and airway fibrosis by inducing proteasomal degradation of its targets and reducing toxicity in animal models.
Targets&IC50
MIAPaCa2 cells:1 μM, non-small cell lung cancer (NSCLC) cell lines:0.08 to 0.24 μM
In vitro
Under 1.0 μM 3-Deazaneplanocin A (DZNep) treatment, OCI-AML3 cells showed an increase in cell number at G0/G1 phase, indicating cell cycle arrest. 3-Deazaneplanocin A treatment for 48 hours was able to dose-dependently inhibit the colony-forming ability of OCI-AML3 and HL-60 cells in the concentration range of 200 nM to 2.0 μM. [1]
In addition, 3-Deazaneplanocin A treatment for 72 hours significantly reduced the expression of EZH2 in several cancer cell lines (e.g., PANC-1, MIA-PaCa-2, and LPc006) by 48%, 32%, and 36%, respectively. Although 3-Deazaneplanocin A had a weak inhibitory effect on the proliferation of PANC-1 cells, it had a stronger inhibitory effect on MIA-PaCa-2 and LPc006 cells, with IC50 values of 1 μM and 0.1 μM, respectively.[2]
In non-small cell lung cancer (NSCLC) cell lines, 3-Deazaneplanocin A also exhibited dose-dependent inhibition of proliferation with IC50 ranging from 0.08 to 0.24 μM.[3]
In vivo
In the NOD/SCID mouse model, the median survival of acute myeloid leukemia (AML) mice was significantly prolonged in the treatment group with the combination of 3-Deazaneplanocin A and Panobinostat (PS) compared to the group with the drug alone and the control group. Specifically, 36 days for the control group, 42 days for PS, 43 days for 3-Deazaneplanocin A, and 52 days for the combination group. [1]
In addition, administration of 20 mg/kg 3-Deazaneplanocin A to rats significantly reduced body weight during the first three days of treatment (2.0%, 4.9%, and 1.2% reductions, respectively), and suppressed the rate of body weight growth to 2.6% per day from the fourth day on. [4]
AliasDZNep, 3-Deazaneplanocin
Chemical Properties
Molecular Weight262.27
FormulaC12H14N4O3
Cas No.102052-95-9
SmilesO[C@H]1[C@H](N2C=3C(N=C2)=C(N)N=CC3)C=C(CO)[C@H]1O
Relative Density.1.75 g/cm3
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 75 mM
H2O: 80.00 mg/mL (305.03 mM), Sonication is recommended
Solution Preparation Table
DMSO/H2O
1mg5mg10mg50mg
1 mM3.8129 mL19.0643 mL38.1286 mL190.6432 mL
5 mM0.7626 mL3.8129 mL7.6257 mL38.1286 mL
10 mM0.3813 mL1.9064 mL3.8129 mL19.0643 mL
20 mM0.1906 mL0.9532 mL1.9064 mL9.5322 mL
50 mM0.0763 mL0.3813 mL0.7626 mL3.8129 mL
H2O
1mg5mg10mg50mg
100 mM0.0381 mL0.1906 mL0.3813 mL1.9064 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy 3-Deazaneplanocin A | purchase 3-Deazaneplanocin A | 3-Deazaneplanocin A cost | order 3-Deazaneplanocin A | 3-Deazaneplanocin A chemical structure | 3-Deazaneplanocin A in vivo | 3-Deazaneplanocin A in vitro | 3-Deazaneplanocin A formula | 3-Deazaneplanocin A molecular weight